IPX vs LXU
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IPX exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor operational health. While the company maintains a strong liquidity position with a Current Ratio of 4.03 and very low debt (D/E 0.04), it is currently plagued by severe profitability issues, including an ROE of -50.42% and a negative forward P/E. There is a stark divergence between the 'Strong Buy' analyst consensus and the actual deterministic data, which shows a bearish technical trend (0/100) and a sharp 6-month price decline of 41.3%.
LXU exhibits a stable financial foundation with a Piotroski F-Score of 6/9, though it currently trades at a significant premium to its Graham Number ($7.45) and Intrinsic Value ($2.38). While explosive earnings growth (YoY EPS +211.1%) and a low PEG ratio (0.42) suggest strong future potential, these are heavily offset by aggressive insider selling totaling $77.79M. The disconnect between the bullish analyst consensus and the bearish insider sentiment and technical trend creates a high-risk profile despite the strong revenue growth.
Compare Another Pair
Related Comparisons
IPX vs LXU: Head-to-Head Comparison
This page compares IperionX Limited (IPX) and LSB Industries, Inc. (LXU) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.